Drugs by condition
Drugs approved for gout
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
11
Still marketed, NDA or BLA
Drug classes
5
Novel drugs
4
New molecular entities and new biologics
In development
15
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for gout.
- Gloperba (Colchicine) · Scilex Pharms Jan 30, 2019
- Mitigare (Colchicine) · Hikma Sep 26, 2014
- Krystexxa (Pegloticase) · Horizon Pharma NovelPriority reviewOrphanSep 14, 2010
- Ilaris (Canakinumab) · Novartis Pharms NovelBreakthrough therapyPriority reviewOrphanJun 17, 2009
- Uloric (Febuxostat) · Takeda Pharms USA NovelFeb 13, 2009
All approved drugs for gout, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 61 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Xanthine Oxidase Inhibitor (4)
- Uloric Febuxostat · Takeda Pharms USA · 2009
- Zyloprim Allopurinol · Casper Pharma LLC · 1966
- Allopurinol Allopurinol · Watson Labs · 1984
- Allopurinol Allopurinol · Watson Labs · 1984
Alkaloid (2)
Nonsteroidal Anti-inflammatory Drug (2)
- Ec-Naprosyn Naproxen · Atnahs Pharma US · 1994
- Naprosyn Naproxen · Atnahs Pharma US · 1987
Uric Acid-specific Enzyme (1)
- Krystexxa Pegloticase · Horizon Pharma · 2010
Class not listed in FDA's data (2)
Drugs in development for gout
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- EtoricoxibPhase 34 trials
Laboratorios Silanes S.A. de C.V. · Gout Arthritis, Gout Attack, Acute Low-back Pain
- AR882Phase 33 trials
Arthrosi Therapeutics · Gout, Hyperuricemia, Gout Chronic
- DotinuradPhase 33 trials
Crystalys Therapeutics · Gout, Tophaceous Gout
- HRS-2129Phase 33 trials
Shandong Suncadia Medicine Co., Ltd. · Acute Gouty Arthritis, Postoperative Analgesia, Postoperative Pain in Orthopaedics
- PlonmarlimabPhase 33 trials
TJ Biopharma Co., Ltd. · Acute Gouty Arthritis, Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis, Hemophagocytic Lymphohistiocytoses
- TigulixostatIBI128, LC350189Phase 33 trials
Innovent Biologics Technology Limited (Shanghai R&D Center) · Gout, Hyperuricemia, Gout Flare
- ABP-671Phase 32 trials
Atom Therapeutics Co., Ltd · Chronic Kidney Disease, Gout
- Combined metabolic activatorsPhase 32 trials
ScandiBio Therapeutics AB · Alzheimer Disease, Gout Disease
- Etoricoxib fixed doseEtoriPhase 32 trials
Laboratorios Silanes S.A. de C.V. · Gout Arthritis, Gout Attack, Acute Low-back Pain
- HR091506Phase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Gout With Hyperuricemia in Adults
- ABP-745Phase 22 trials
Atom Therapeutics Co., Ltd · Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
- BR2251Phase 21 trial
BioRay Pharmaceutical Co., Ltd. · Gout and Hyperuricemia
- IG3018Phase 21 trial
Intelligem Therapeutics Australia Pty Ltd. · Hyperuricemia, Hypouricemia, Renal
- PRX-115Phase 21 trial
Protalix · Gout
- SSGJ-613Phase 21 trial
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Gout Arthritis
1 discontinued brand-name drugs whose label still names it
- Colcrys Colchicine
More on gout: recruiting trials · published research
Related in immunology and inflammation: Rheumatoid arthritis · Plaque psoriasis · Psoriatic arthritis · Atopic dermatitis (eczema) · Crohn's disease · Ulcerative colitis · Ankylosing spondylitis · Lupus (SLE) · Hidradenitis suppurativa · Chronic hives (urticaria)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.